Objectif
There is now an increasingly solid body of scientific evidence which demonstrates that the binding of small molecular weight compounds, peptides and antibodies (Abs) to fusion-intermediate conformations of gp41 leads to an inhibition of HIV cell entry. The principal aim of this project is to exploit this information by establishing a platform where gp41-derived vaccine candidates will be designed to elicit neutralising Abs. Several families of immunogens which mimic gp41 in its fusion intermediate conformations are already available and others will be designed using modelisation approaches. Candidates will be submitted to a thorough biophysical characterisation followed by a preclinical development in order to identify the most promising for clinical evaluation. A crucial selection parameter is the capacity of antigens to elicit neutralising Abs using internationally standardized assays. Since sexual transmission accounts for more than 90% of HIV infection, the capacity of Abs to inhibit infection at the mucosal level will also be determined. This cross-disciplinary project gathers top European scientists with expertise in protein engineering and characterisation, adjuvantation, formulation for systemic and mucosal delivery, evaluation of functional antibody response, efficacy testing in animal models, medium to large scale vaccine production as well as conduct of clinical trials in both developed and third-world countries. In contrast to previous more empirical attempts, this project is based on the rational exploitation of the knowledge on the mechanism of HIV entry and is thus a promising approach to generate a protective vaccine. It will be the first European project targeting intermediate conformations of gp41 and it could complement/synergize other international strategies focusing on the membrane proximal region of gp41 or gp140 trimer to induce neutralising Abs or aiming at reducing the viral load by eliciting a cellular immunity against HIV.
Champ scientifique
Mots‑clés
Appel à propositions
FP7-HEALTH-2007-A
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
69007 Lyon
France
Voir sur la carte
Participants (18)
13353 Berlin
Voir sur la carte
18071 Granada
Voir sur la carte
93053 REGENSBURG
Voir sur la carte
2970 Hoersholm
Voir sur la carte
38027 GRENOBLE
Voir sur la carte
BT7 1NN Belfast
Voir sur la carte
3400 Klosterneuburg
Voir sur la carte
1024 Budapest
Voir sur la carte
75015 PARIS 15
Voir sur la carte
SW17 0RE London
Voir sur la carte
NW3 2QG London
Voir sur la carte
6110 Port-Au-Prince
Voir sur la carte
Participation terminée
1227 CAROUGE
Voir sur la carte
67081 Strasbourg
Voir sur la carte
75654 Paris
Voir sur la carte
01707 NEYRON
Voir sur la carte
SW7 2AZ LONDON
Voir sur la carte
GU2 7XH Guildford
Voir sur la carte